FDBusiness.com

New clinically proven Flowens™ opens the door to fresh men’s health opportunities

 Breaking News
  • Lactalis Expands in Infant Nutrition With €740 Million Acquisition Lactalis Group, the international dairy group based in Laval, France, is acquiring the Nutritional business of Aspen Pharmacare for €739.8 million (R12.9 billion). The business being acquired supplies a wide range of infant nutritional and growing-up milk products across both the premium and value segments. It manufactures and markets well established quality brands, including S-26, [...]...
  • Thatchers Cider to Invest £14 Million in New Cider Mill Thatchers Cider, the family owned English cider producer, is to invest £14 million in a new cider mill at its Myrtle Farm site in Somerset to meet growing demand for its products. The company has applied for planning permission and, if granted, the new mill would come on stream in 2019. “This investment is about our [...]...
  • Coca-Cola Great Britain Teams Up With Premier League Premier League and Coca-Cola Great Britain have announced a new three-and-a-half-year partnership, starting in January 2019. It is the first sponsorship Coca-Cola Great Britain will activate across multiple brands within its portfolio, showcasing a range of drinks including sparkling soft drinks, water and fruit-based drinks, with low and no-sugar options. The partnership will see Coca-Cola work [...]...
  • Barry Callebaut Completes $30 Million Capacity Expansion in North America Barry Callebaut, the world’s leading manufacturer of high-quality chocolate and cocoa products, has announced the completion of several expansion investments in three of its North American facilities located in St Hyacinthe, Quebec; Chatham, Ontario; and St Albans, Vermont. The investments amount to close to US$30 million and are in line with previously announced plans. Recent investments [...]...
  • Strong First Half From Hilton Food Group Hilton Food Group, the UK-based leading specialist international food packing business, has reported a 25.0% increase in turnover to £863.6 million and by 24.5% on a constant currency basis for the 28 weeks to 15 July 2018. Volumes increased by 12.7% reflecting growth in the UK, Ireland and Australia. Operating profit for the first half [...]...

New clinically proven Flowens™ opens the door to fresh men’s health opportunities

April 23
11:28 2014

Avignon, 24th April 2014 – Naturex has launched a natural, clinically proven botanical ingredient that addresses an uncomfortable prostate condition common among men – without causing any side effects.

Flowens™ is a full spectrum cranberry powder engineered to relieve the lower urinary tract symptoms typically associated with benign prostatic hyperplasia (BPH). It offers an effective and safe alternative to existing pharmaceutical remedies and other, less effective botanical options. BPH can cause an overactive bladder, leading to increased frequency of urination, or an underactive bladder, resulting in hesitancy, intermittency, weak stream and an inability to empty the bladder fully. The symptoms can impair quality of life.

Research suggests 26% of men in their 40s display lower urinary tract symptoms that are moderate to severe, with this figure rising to 33% for men in their 60s, 41% for men in their 70s, and 50% for men in their 80s. The numbers of men affected illustrates the significant market potential for an effective ingredient that helps alleviate BPH without any side effects – such as Flowens™.

Flowens™, which has been developed by Naturex for use in nutritional supplements and functional foods, is proven to ease the lower urinary tract symptoms typically associated with BPH. In a recent gold-standard clinical trial, patients with lower urinary tract symptoms who took Flowens™ experienced strong improvements in the key prostrate health marker – the International Prostrate Symptom Score (IPSS) – compared with a placebo.

Improvements in the IPSS were more marked as the intake was increased, with a 250mg daily dose of Flowens™ providing a 25% improvement and a 500mg daily dose offering a 44% improvement.

Dan Souza, Senior Director of Sales & Marketing at Naturex, said: “This trial demonstrates that Flowens™ is highly effective in alleviating the lower urinary tract symptoms typically associated with BPH, a condition that troubles millions of men across Europe. With so many sufferers, the market potential is enormous. Flowens™ is not only effective, but it is also free of the side effects associated with most pharmaceuticals in this space.”

Flowens™ will make its European debut at Vitafoods Europe, which takes place in Geneva from 6 to 8 May 2014. Naturex will exhibit on Stand 18033. Dan Souza is also scheduled to speak about the new ingredient at a seminar in the exhibition’s presentation theatre on 6 May 2013, from 3.10pm-3.40pm.

 

About Author

admin

admin

Related Articles



Food & Drink Business Conference & Exhibition 2016

Upcoming Events

  • September 15, 2018iba
  • September 25, 2018PPMA Show 2018
  • September 27, 2018Int'l Fruit Show (eurofruit)
  • September 30, 2018Trade Fair for Butchers, Caterers and Meat Industry (Meat Expo)
AEC v1.0.4

find food jobs

The Magazine

F&D Business Preferred Suppliers

New Subscriber





Subscribe Here



Advertisements